Calcium/Calmodulin-Dependent Protein Kinase Signaling in Cancer Biology

Calcium ions act as ubiquitous second messengers that regulate a myriad of cellular processes, and their decoding is chiefly mediated by the calcium-binding protein calmodulin. Upon binding calcium, calmodulin undergoes a conformational change that enables it to activate a family of serine/threonine kinases known as calcium/calmodulin-dependent protein kinases (CaMKs). Central to this network are CaMKK1 and CaMKK2, upstream kinases that phosphorylate and activate downstream effectors such as CaMKI, CaMKIV and AMP-activated protein kinase (AMPK), as well as non-canonical substrates including Akt. These cascades translate transient calcium fluxes into sustained kinase activity, modulating processes such as cell proliferation, survival, migration and metabolism.

In cancer biology, dysregulation of CaMK signalling contributes to tumour initiation, progression and therapy resistance. Aberrant CaMKK2 expression, for example, can enhance cell survival through AMPK-dependent metabolic adaptation and through direct activation of Akt in certain malignancies. Moreover, CaMKII isoforms, with both enzymatic and scaffolding roles, influence oncogenic signalling by modifying the cytoskeleton, gene transcription and apoptotic thresholds. The breadth of CaMK interactions extends to the tumour microenvironment, where they can reprogramme immune cell function and angiogenesis.

Therapeutic targeting of CaMK pathways is gaining traction, with specific inhibitors developed for CaMKK2 and distinct classes of CaMKII inhibitors now available. These tools allow precise interrogation of cancer-associated CaMK functions and hold promise for combination strategies that sensitize tumours to chemotherapy or immunotherapy. The global significance of this signalling axis is underlined by its involvement in diverse cancer types, from breast and ovarian to prostate and leukaemia, making CaMKs attractive targets for broad-spectrum and personalised interventions.

Research from Nature Portfolio

Recent studies have identified CaMKK2 as a pivotal regulator of the immune-suppressive microenvironment in breast cancer. In murine models, selective deletion or pharmacological inhibition of CaMKK2 within tumour-associated myeloid cells led to a marked reduction in tumour growth and an influx of cytotoxic T lymphocytes. Mechanistically, CaMKK2 inhibition reprogrammed macrophage cytokine profiles, enhancing chemokine secretion that attracts effector T cells and diminishing immunosuppressive phenotypes. These findings position CaMKK2 as a myeloid-selective checkpoint whose targeting may synergise with existing immunotherapies to overcome immune evasion in solid tumours.

Calcium/Calmodulin-Dependent Protein Kinase Signaling in Cancer Biology publication trend

The graph below shows the total number of articles in calcium/calmodulin-dependent protein kinase signaling in cancer biology across all publications each year (not limited to Nature Index journals).

Technical terms

Calmodulin: A calcium-binding messenger protein that transduces Ca²⁺ signals by activating target enzymes and kinases.

CaMKK2: Calcium/calmodulin-dependent protein kinase kinase 2, an upstream kinase that activates CaMKI, CaMKIV, AMPK and non-canonical targets such as Akt.

CaMKII: Calcium/calmodulin-dependent protein kinase II, a family of multifunctional kinases modulating cytoskeletal dynamics, transcription and cell survival.

Phosphorylation: The enzymatic addition of a phosphate group to a protein, often regulating its activity or interactions.

Akt (Protein Kinase B): A serine/threonine kinase central to cell growth and survival pathways, activated by phosphorylation at multiple sites.

Tumour microenvironment: The cellular milieu surrounding cancer cells, including immune cells, fibroblasts, blood vessels and extracellular matrix.

References

1. Studying CaMKII: Tools and standards. Cell Reports (2024).
2. CaMKK2: bridging the gap between Ca2+ signaling and energy-sensing. Essays in Biochemistry (2024).
3. Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells. Journal of Biological Chemistry (2017).
4. CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer. Nature Communications (2019).